ArticleBioethics2026
Clinical Ethicists and Medical Assistance in Dying (MAiD): Possible Roles and Challenges.
Article in Bioethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assisted dying (AD) presents a range of challenges for clinical ethicists (CEs) and healthcare institutions seeking to involve them in its provision. Questions regarding the legitimacy, scope, and nature of CE involvement remain underexplored in the literature. This article addresses this gap by first outlining the professional standards that guide CE practice and presenting arguments for the value of ethics expertise in AD contexts. We then examine the Canadian MAiD landscape and draw on the experiences of CEs-particularly within a healthcare institution in Quebec-to propose a typology of roles that CEs have occupied at various moments and levels throughout the emergence and institutionalization of AD. These roles span micro to macro levels of involvement and reflect both practical contributions and normative considerations. In the final section, we return to the foundational normative questions raised at the outset-not to offer definitive answers, but to contribute meaningfully to ongoing reflection about CE involvement in AD. By analyzing professional standards alongside the diverse roles CEs have played, we assess the benefits and challenges of their participation in this ethically complex domain and offer guidance for institutions seeking to engage ethics expertise in AD policy and practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.